Philip Berardi

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Replacement Therapy

Tyrosine Kinase

Epidermal Growth Factor Receptor

Acute Lymphoblastic Leukemia

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Julie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne R Mahé, Philip Berardi, Mark D Minden, Joseph M Brandwein, Andre C Schuh
The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Current oncology (Toronto, Ont.) 30 (12) (2023)
Julie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne R Mahé, Philip Berardi, Mark D Minden, Joseph M Brandwein, Andre C Schuh
The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Current oncology (Toronto, Ont.) 30 (12) (2023)
Julie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne R Mahé, Philip Berardi, Mark D Minden, Joseph M Brandwein, Andre C Schuh
The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Current oncology (Toronto, Ont.) 30 (12) (2023)
Julie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne R Mahé, Philip Berardi, Mark D Minden, Joseph M Brandwein, Andre C Schuh
The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Current oncology (Toronto, Ont.) 30 (12) (2023)
Julie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne R Mahé, Philip Berardi, Mark D Minden, Joseph M Brandwein, Andre C Schuh
The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Current oncology (Toronto, Ont.) 30 (12) (2023)
Julie Bergeron, Jose-Mario Capo-Chichi, Hubert Tsui, Etienne R Mahé, Philip Berardi, Mark D Minden, Joseph M Brandwein, Andre C Schuh
The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus. Current oncology (Toronto, Ont.) 30 (12) (2023)